Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Myocardial Fibrosis in Hypertrophic Cardiomyopathy: What Remains to be Proven?

Literature DB >> 30916192

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: What Remains to be Proven?

Leonardo Sara¹.

Abstract

Entities: Chemical Disease Species

Mesh：

Year: 2019 PMID： 30916192 PMCID： PMC6424026 DOI： 10.5935/abc.20190043

Source DB: PubMed Journal: Arq Bras Cardiol ISSN： 0066-782X Impact factor: 2.000

Keyword Cloud
References

× No keyword cloud information.

10 in total

1. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors: Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal: J Am Coll Cardiol Date: 2011-11-08 Impact factor: 24.094

Review 2. Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: the importance of clinical context.

Authors: Giovanni Quarta; Giovanni Donato Aquaro; Patrizia Pedrotti; Gianluca Pontone; Santo Dellegrottaglie; Attilio Iacovoni; Paolo Brambilla; Silvia Pradella; Giancarlo Todiere; Fausto Rigo; Chiara Bucciarelli-Ducci; Giuseppe Limongelli; Alberto Roghi; Iacopo Olivotto
Journal: Eur Heart J Cardiovasc Imaging Date: 2018-06-01 Impact factor: 6.875

3. Perspectives on the Overall Risks of Living With Hypertrophic Cardiomyopathy.

Authors: Barry J Maron; Martin S Maron; Ethan J Rowin
Journal: Circulation Date: 2017-06-13 Impact factor: 29.690

Review 4. Clinical Course and Management of Hypertrophic Cardiomyopathy.

Authors: Barry J Maron
Journal: N Engl J Med Date: 2018-08-16 Impact factor: 91.245

Review 5. Prognostic Value of LGE-CMR in HCM: A Meta-Analysis.

Authors: Zhen Weng; Jialu Yao; Raymond H Chan; Jun He; Xiangjun Yang; Yafeng Zhou; Yang He
Journal: JACC Cardiovasc Imaging Date: 2016-07-20

6. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.

Authors: Raymond H Chan; Barry J Maron; Iacopo Olivotto; Michael J Pencina; Gabriele Egidy Assenza; Tammy Haas; John R Lesser; Christiane Gruner; Andrew M Crean; Harry Rakowski; James E Udelson; Ethan Rowin; Massimo Lombardi; Franco Cecchi; Benedetta Tomberli; Paolo Spirito; Francesco Formisano; Elena Biagini; Claudio Rapezzi; Carlo Nicola De Cecco; Camillo Autore; E Francis Cook; Susie N Hong; C Michael Gibson; Warren J Manning; Evan Appelbaum; Martin S Maron
Journal: Circulation Date: 2014-08-05 Impact factor: 29.690

7. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

Authors: Perry M Elliott; Aris Anastasakis; Michael A Borger; Martin Borggrefe; Franco Cecchi; Philippe Charron; Albert Alain Hagege; Antoine Lafont; Giuseppe Limongelli; Heiko Mahrholdt; William J McKenna; Jens Mogensen; Petros Nihoyannopoulos; Stefano Nistri; Petronella G Pieper; Burkert Pieske; Claudio Rapezzi; Frans H Rutten; Christoph Tillmanns; Hugh Watkins
Journal: Eur Heart J Date: 2014-08-29 Impact factor: 29.983